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Background: The present study was conducted to assess the nature of sympathovagal imbalance (SVI) in
prehypertensives by short-term analysis of heart rate variability (HRV) to understand the alteration in autonomic
modulation and the contribution of BMI to SVI in the genesis of prehypertension.
Methods: Body mass index (BMI), basal heart rate (BHR), blood pressure (BP), rate pressure product (RPP) and HRV
indices such as total power (TP), low-frequency power (LF), normalized LF (LFnu), high-frequency power (HF),
normalized HF (HFnu), LF-HF ratio, mean heart rate (mean RR), square root of the mean squared differences of
successive normal to normal intervals (RMSSD), standard deviation of normal to normal RR interval (SDNN), the
number of interval differences of successive NN intervals greater than 50 ms (NN50) and the proportion derived by
dividing NN50 by the total number of NN intervals (pNN50) were assessed in three groups of subjects:
normotensives having normal BMI (Group 1), prehypertensives having normal BMI (Group 2) and prehypertensives
having higher BMI (Group 3). SVI was assessed from LF-HF ratio and correlated with BMI, BHR, BP and RPP in all the
groups by Pearson correlation. The contribution of BMI to SVI was assessed by multiple regression analysis.
Results: LF and LFnu were significantly increased and HF and HFnu were significantly decreased in prehypertensive
subjects in comparison to normotensive subjects and the magnitude of these changes was more prominent in
subjects with higher BMI compared to that of normal BMI. LF-HF ratio, the sensitive indicator of sympathovagal
balance had significant correlation with BMI (P = 0.000) and diastolic blood pressure (DBP) (P = 0.002) in
prehypertensives. BMI was found to be an independent contributing factor to SVI (P = 0.001) in prehypertensives.
Conclusions: It was concluded that autonomic imbalance in prehypertensives manifested in the form of increased
sympathetic activity and vagal inhibition. In prehypertensives with higher BMI, vagal withdrawal was predominant
than sympathetic overactivity. Magnitude of SVI (alteration in LF-HF ratio) was linked to changes in BMI and DBP.
BMI had an independent influence on LF-HF ratio. It was advised that life-style modifications such as yoga and
exercise would enable achieve the sympathovagal balance and blood pressure homeostasis in prehypertensives.
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Hypertension is among the major risk factors for prema-
ture disability and death in both Western [1,2] and Asian
[3] populations. Especially, Asian Indians have been
reported to be at increased risk of diabetes, hypertension
and heart diseases [4,5]. Though the increased risk of
cardiovascular events in Indian population has been* Correspondence: drgkpal@gmail.com
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reproduction in any medium, provided the orattributed to genetic predisposition [6], there is a strong
correlation between changing lifestyle and increasing in-
cidence of hypertension and heart diseases [7,8]. Studies
have reported that sustained sympathetic overactivity,
which increases vasoconstrictor tone of the systemic vas-
culature acts as a major mechanism for genesis of essen-
tial hypertension [9-11]. Though, several studies have
revealed autonomic imbalance in hypertensive patients
[12,13], there is paucity of data on the nature of auto-
nomic imbalance that slowly leads to the progression
from normotensive state into the state of prehyperten-
sion. Nevertheless, prehypertension has recently been. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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vasculature and adverse cardiovascular events [14-16].
Recent reports from our laboratory based on the
spectral analysis of heart rate variability (HRV) reveal
that sympathovagal imbalance in the form of sympa-
thetic overactivity and vagal withdrawal contributes to
the development of prehypertension and hypertension
in Indian population [17-19]. Our previous studies
have revealed prehypertension is more prevalent
among males and vagal withdrawal is more promin-
ent compared to sympathetic overactivity in male pre-
hypertensives [20,21]. We have also reported from the
studies on young prehypertensives with parental his-
tory of hypertension that sympathovagal imbalance
(SVI) is more intense in offspring of two parents
hypertensive compared to the offspring of one parent
hypertensive [22]. Yet, till date the exact mechanism
of alteration in sympathovagal imbalance in prehyper-
tensives has not been fully ascertained. Recently, con-
tribution of obesity to the genesis of hypertension
has been fully established [23]. However, no study
has yet thoroughly evaluated the link of body mass
index (BMI) with the causation of prehypertension.
Spectral analysis of HRV has been used as a sensitive
tool for assessment of autonomic dysfunctions in
various clinical disorders [24]. Therefore, in the
present study we have attempted to assess the nature
and magnitude of autonomic imbalance and the role
of BMI as an independent contributor to the genesis
of SVI in prehypertensives.Methods
Subjects
After obtaining the approval of Research Council and In-
stitutional Ethics Committee, of Jawaharlal Institute of
Post-graduate Medical Education and Research (JIPMER),
Puducherry, India, 108 subjects were recruited from medi-
cine out-patient department and staff of JIPMER. All the
subjects underwent routine clinical examination to rule
out the presence of any acute or chronic illness. It was
ensured that all the subjects were healthy and physically
fit to be included in the study. Eligible participants were
interviewed and were explained about their participation
and the nature of investigations to be conducted in the
project. Informed written consent was obtained from all
of them prior to the recordings.
The subjects between 25 to 45 years of age were
included in the study. They were classified into follow-
ing three groups based on their level of systolic and
diastolic blood pressure as per JNC-7 classification [25]
and the level of body mass index (BMI) as per the
recommendation of world health organization (WHO)
on BMI for Asian population [26].1. Group 1 : Normotensive subjects with normal BMI
(n = 45): Healthy subjects having systolic BP 100–
119 mm Hg, diastolic BP 60–79 mmHg, and BMI
18.5-22.9.
2. Group 2 : Prehypertensive subjects with normal
BMI (n = 27): Healthy subjects having systolic BP
120–139 mm Hg, diastolic BP 80–89 mmHg, and
BMI 18.5-22.9.
3. Group 3 : Prehypertensive subjects with higher BMI
(n = 36): Healthy subjects having systolic BP 120–
139 mm Hg, diastolic BP 80–89 mmHg, and BMI 23
or above.
In the study population, there was no normotensive
subject having higher BMI. Subjects were excluded from
the study if they met any of the following criteria: (1)
Subjects on antihypertensive therapy or receiving any
medication, (2) subjects with history of smoking or alco-
holism, (3) subjects with acute or chronic ailments, (4)
subjects performing regular sports activities, and (5)
known cases of diabetes mellitus, hypertension, myocar-
dial infarction, heart failure, kidney disease or any
endocrinal disorder. As the level of physical fitness is a
major determinant of vagal tone [27,28], subjects per-
forming regular athletic activities and body-building
exercises were excluded from the study.
Laboratory conditions and BP recording
Subjects were asked to report to autonomic function
testing (AFT) laboratory of physiology department at
about 9 AM following a light breakfast, without tea or
coffee. The temperature of AFT laboratory was main-
tained at 25°C for all the recordings. After obtaining the
informed consent, their age, height, body weight and
body mass index were recorded. BP of all the subjects
was recorded in AFT laboratory. Omron (SEM 1
Model), the automatic blood pressure monitor (Omron
Healthcare Co. Ltd, Kyoto, Japan) was used for BP
recording. The cuff size of Omron was 121 mm
(width) × 446 mm (length), which was appropriate for all
the subjects in the study. The length of the cuff tube
was 600 mm. For BP recording, the subject was asked to
sit upright with back straight on a wooden armed chair
keeping one forearm on a wooden table kept in front
and close to the subject. The height of the table was
such that the middle of the arm placed on the table ap-
proximately coincided with the level of the heart. The
subject was asked to keep the other forearm on the side
hand rest of the chair. The BP cuff was tied just tight
(neither too tight nor loose) on the arm approximately
2 cm above the cubital fossa. It was ensured that the BP
cuff was at the level of the heart. After five minutes of
rest in the same sitting posture, the ‘Start’ button of
Omron was pressed that automatically inflated and
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(BHR) were noted from the display screen of the equip-
ment. For each subject, SBP, DBP and BHR were
recorded in each arm twice at an interval of five minutes
between the recordings, and for each parameter the
mean of the four recordings was considered. Rate pres-
sure product (RPP) was calculated using the formula,
RPP = systolic pressure × heart rate × 10–2 [29].
HRV recording
After 15 minutes of supine rest on a couch in AFT lab,
ECG was recorded for 5 minutes for short-term HRV
analysis following the standard procedures as practiced
in the laboratory. For recording of HRV, recommenda-
tion of the Task Force on HRV was followed [30]. For
the purpose, ECG electrodes were connected and Lead
II ECG was acquired at a rate of 1000 samples/second
during supine rest using BIOPAC MP 100 data acquisi-
tion system (BIOPAC Inc., USA). The data was trans-
ferred from BIOPAC to a windows-based PC with
Acqknowledge software version 3.8.2. Ectopics and arte-
facts were removed from the recorded ECG. RR tacho-
gram was extracted from the edited 256 sec ECG using
the R wave detector in the Acqknowledge software and
saved in ASC-II format which was later used offline for
HRV analysis. HRV analysis was done using the HRV
software version 1.1 (Bio-signal analysis group, Finland).
Following frequency domain and time-domain indices
were calculated from the HRV recordings.
A. Frequency domain indices (FDI)
1. Total power (TP)
2. Low frequency power (LF)
3. Normalized LF power (LFnu)
4. High frequency power (HF)
5. Normalized HF power (HFnu)
6. LF-HF ratioTable 1 Age, anthropometric and basal cardiovascular param
Parameters Group 1 Group 2
(n = 45) (n = 27)
Age (Yrs) 35.70 ± 6.80 36.30 ±
Body Weight (Kg) 55.58 ± 4.56 56.04 ±
BMI (Kg/m2) 21.16 ± 2.12 21.42 ±
BHR (per min) 69.80 ± 7.94 74.60 ±
SBP (mmHg) 108.65 ± 6.21 128.80 ±
DBP (mmHg) 71.80 ± 5.45 84.56 ±
RPP (mmHg/min) 73.70 ± 6.40 80.41 ±
Data presented are mean ± SD; Group 1: Normotensive subjects with normal BMI; G
subjects with higher BMI; The * mark indicates comparison with normotensive subj
prehypertensive subjects with normal BMI. ** p <0.01; *** p <0.001; ## p <0.01; ###B. Time-domain indices (TDI)
1. Mean heart rate (Mean RR)
2. Square root of the mean squared differences of
successive normal to normal intervals (RMSSD)
of HRV
3. Standard deviation of normal to normal interval
(SDNN)
4. The number of interval differences of successive
NN intervals greater than 50 ms (NN50)
5. The proportion derived by dividing NN50 by the
total number of NN intervals (pNN50)
Statistical analysis of data
SPSS version 13 (SPSS Software Inc., Chicago, IL, USA)
and GraphPad InStat softwares (GraphPad Software Inc.,
San Diego, CA, USA) were used for statistical analysis.
All the data were expressed as mean ± SD. Normality of
data was tested by Kolmogorov Smironov test. For para-
metric data, the level of significance between the groups
was tested by Student’s unpaired two-tailed ‘t’ test and
for nonparametric data, the Welch’s corrected t test was
used. Statistical analysis of data within the three groups
was done by one-way ANOVA and post-hoc by Tukey-
Krammer test. The association between LF-HF ratio and
BMI with BHR, blood pressure and RPP was assessed by
Pearson correlation analysis. The independent contribu-
tion of various factors such as age, BMI, BHR, SBP and
DBP to sympathovagal imbalance (LF-HF ratio) was
assessed by multiple regression analysis. The P values
less than 0.05 was considered statistically significant.
Results
There was no significant difference in age among all the
three groups (Table 1). Though there was no significant
difference in body weight and BMI between groups 1
and 2, body weight and BMI of group 3 were signifi-
cantly increased compared to that of groups 1 and 2.eters in different groups
Group 3 p values
(n = 36)
7.25 37.12 ± 6.62 0.6521
8.52 65.10 ± 6.20***,## <0.000
1.78 27.80 ± 3.40***,### <0.0001
7.30 85.10 ± 8.20***,### <0.0001
7.20*** 131.60 ± 8.25*** <0.0001
3.75*** 85.76 ± 4.10*** <0.0001
7.32** 110.67 ± 7.92***,### <0.0001
roup 2: Prehypertensive subjects with normal BMI; Group 3: Prehypertensive



























Group 1 Group 2 Group 3 
Figure 1 Low frequency (LF) and high frequency (HF) powers
as mean percentage of total power (TP) of heart rate variability
(HRV) spectrum. Group 1: Normotensives having normal BMI;
Group 2: Prehypertensives having normal BMI; Group 3:
Prehypertensives having higher BMI.
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was not significant, BHR was significantly increased in
group 3 compared to BHR of groups 1 and 2 (p< 0.001).
SBP and DBP of groups 2 and 3 were significantly higher
(p< 0.001) compared to that of group 1, though the dif-
ference was not significant between groups 2 and 3. RPP
of groups 2 and 3 was significantly more compared to
that of group 1 and RPP of group 3 was significantly
more (p< 0.001) than that of group 2.
Total power (TP) of HRV spectrum of groups 2 and 3
was significantly decreased compared to that of group 1.
Also, TP of group 3 was significantly less (p< 0.001)
than that of group 2 (Table 2). Though there was no sig-
nificant difference in LF power between groups 1 and 2,
it was significantly less (p< 0.01) in group 3 compared
to that of both groups 1 and 2. However, LF power
expressed as % of TP was more in group 2 and 3 com-
pared to that of group 1 (Figure 1). The HF power of
groups 2 and 3 was significantly less (p< 0.001) than
that of group 1, and HF power of group 3 was signifi-
cantly less (p< 0.001) than that of group 2. Also, HF
power expressed as % of TP was less in groups 2 and 3
compared to that of group 1 (Figure 1). Though LFnu of
group 2 (p< 0.05) and group 3 (p< 0.001) was signifi-
cantly increased compared to that of group 1, change in
LFnu was not significant between groups 2 and 3. HFnu
of groups 2 and 3 was significantly low compared to
that of group 1. Also, HFnu was decreased significantly
(p< 0.05) in group 3 compared to that of group 2. LH-
HF ratio was increased significantly in groups 2 and 3
compared to that of group 1 and the LH-HF ratio ofTable 2 Frequency and time domain indices of HRV recorded
Parameters Group 1 Group 2
(n = 45) (n = 27)
FDI
TP (ms2) 980.80 ± 376.80 736.57 ± 245
LF (ms2) 390.40 ± 186.70 382.64 ± 180
HF (ms2) 548.30 ± 256.80 325.20 ± 136
LFnu 40.32 ± 19.90 53.90 ± 20.3
HFnu 57.12 ± 21.80 46.05 ± 18.1
LF:HF ratio 1.36 ± 0.65 2.34 ± 1.05
TDI
Mean RR (s) 0.859 ± 0.152 0.804 ± 0.14
RMSSD (ms) 34.10 ± 15.30 28.90 ± 11.3
SDNN (ms) 32.40 ± 17.20 28.50 ± 12.2
NN50 26.40 ± 11.20 22.64 ± 10.7
pNN50 8.90 ± 3.10 7.45 ± 2.50
Data presented are mean ± SD; Data of all parameters listed in this table are nonpa
Group 2: Prehypertensive subjects with normal BMI; Group 3: Prehypertensive subje
subjects with normal BMI and the # mark indicates comparison with prehypertensiv
## p <0.01; ### p <0.001.group 3 was significantly higher (p< 0.001) than the
group 2 (Table 2).
Mean-RR, RMSSD, SDNN, NN50 and pNN50 were
decreased significantly in group 3 compared to that ofin supine position of subjects in various groups
Group 3 p values
(n = 36)
.60** 425.30 ± 186.40***,### <0.0001
.40 254.30 ± 130.50**,## 0.0006
.10*** 142.40 ± 78.90***,### <0.0001
0* 60.56 ± 24.70*** 0.0004
0* 35.28 ± 12.08***,# <0.0001
** 3.76 ± 1.40***,### <0.0001
0 0.700 ± 0.120 ***,# <0.0001
0 19.25 ± 7.45***,## <0.0001
0 20.10 ± 9.20**,# 0.0005
0 17.05 ± 7.80***,# 0.0003
5.10 ± 1.80***,## <0.0001
rametric except Mean RR. Group 1: Normotensive subjects with normal BMI;
cts with higher BMI; The * mark indicates comparison with normotensive
e subjects with normal BMI. * p< 0.05; ** p <0.01; *** p <0.001; # p< 0.05;
Table 3 Pearson correlation of LF-HF ratio with age, BMI,
basal heart rate, blood pressure and rate pressure
product (RPP) of subjects of various groups
Group 1 Group 2 Group 3
r p r p r p
Age 0.072 0.683 0.171 0.393 0.050 0.774
BMI 0.121 0.490 0.156 0.438 0.230 0.295
BHR 0.087 0.620 0.202 0.311 0.234 0.170
SBP 0.131 0.452 0.113 0.575 0.017 0.921
DBP 0.117 0.505 0.542 0.003 0.456 0.009
RPP 0.085 0.629 0.186 0.354 0.207 0.225
The p values less than 0.05 was considered significant. Group 1: Normotensive
subjects with normal BMI; Group 2: Prehypertensive subjects with normal BMI;
Group 3: Prehypertensive subjects with higher BMI.
Table 5 Multiple regression analysis of LF-HF ratio (as
dependable variable) with various other associated
factors (as independent variables) in the entire











Age 0.018 −0.043 0.051 0.871
BMI 0.392 0.046 0.179 0.001
BHR 0.276 0.004 0.053 0.022
SBP −0.036 −0.058 0.042 0.755
DBP 0.187 −0.015 0.158 0.101
p< 0.05 considered significant.
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meters was not significant between groups 1 and 2
(Table 2).
Pearson correlation analysis was done to assess the
strength of association of various factors with LF-HF
ratio or BMI. In group 1, the correlation of LH-HF ratio
was not significant with any of the parameters, and in
groups 2 and 3, LF-HF ratio had significant correlation
only with DBP (Table 3). As the association of BMI with
LF-HF ratio was not found to be significant in groups 2
and 3, their correlation was assessed in the entire prehy-
pertensive group. In all the prehypertensive subjects
taken together, LF-HF ratio showed significant correl-
ation with all the parameters except for age and SBP and
correlation of BMI was significant with all the para-
meters except for age (Table 4).
Multiple regression analysis was carried out to assess
the independent contribution or link of various para-
meters to LF-HF ratio in prehypertensive population.
BMI and BHR were found to have significant impact on
LF-HF ratio (Table 5). BMI as an independent factor had
maximum contribution (p = 0.001) to LF-HF ratio. Mul-
tiple regression analysis was not carried out forTable 4 Pearson correlation of LF-HF ratio and BMI with
various parameters of all the prehypertensive subjects
(n = 63)
LF-HF Ratio BMI
r p r p
Age 0.034 0.789 0.160 0.211
BMI 0.543 0.000
BHR 0.470 0.000 0.366 0.003
SBP 0.197 0.122 0.291 0.021
DBP 0.388 0.002 0.309 0.014
RPP 0.294 0.019 0.482 0.000
LF-HF ratio 0.543 0.000
The p values less than 0.05 was considered significant.normotensive population, as the correlation of LF-HF
ratio was not significant with any of the parameters in
group 1 (Table 3).
Discussion
In the present study, significant decrease in total power
(TP) of HRV spectrum in prehypertensive population
(groups 2 and 3) compared to that of normotensive
population (group 1) represents a substantial decrease in
heart rate variability, which indicates decreased power of
vagal drive in these subjects as TP in general reflects the
vagal potency of cardiac modulation [24,30]. This was
supported by a decrease in absolute HF power and HFnu
in prehypertensive subjects, as HF and HFnu are the in-
dices of parasympathetic drive to the heart [24,30]. Fur-
thermore, TP, HF and HFnu were significantly low in
prehypertensive subjects with higher BMI (group 3)
compared to the subjects of normal BMI (group 2)
(Table 2) indicating the greater decrease in vagal drive in
obese prehypertensive subjects.
A report by Wang et al has revealed increased sympa-
thetic activity in prehypertensives [31], which was con-
firmed by our recent study [17]. In the present study we
have observed a similar change in the form of increased
LFnu in prehypertensives compared to their normoten-
sive counterparts (Table 2). Though there was an appar-
ent decrease in absolute LF power in groups 2 and 3
(Table 2), which is due to the decrease in TP of HRV, LF
when expressed as % of TP was much increased in these
subjects (Figure 1). Thus, these findings confirm the
increased state of sympathetic drive in prehypertensive
subjects as LF represents sympathetic modulation
[24,30]. LF-HF ratio is a sensitive measure of sympatho-
vagal balance [24,30]. Increase in this ratio indicates
increased sympathetic activity [24,30]. LF-HF ratio was
significantly increased (p< 0.001) in prehypertensive
subjects (groups 2 and 3) compared to the normotensive
subjects (group 1), which indicates a heightened
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study, in spite of the modest sample size, we found a big
difference in LF-HF ratio between normotensive and pre-
hypertensive groups, which was not observed in previous
studies [32-34]. This difference in observation could be
due to the racial difference in basal LF-HF ratio and the
difference in altered cardiovascular autonomic tone in re-
sponse to rise in blood pressure, supported by previous
report on ethnic variation in HRV indices and the auto-
nomic responses to stress [35]. However, till date, no re-
port is available on the nature of alteration in
sympathovagal balance that tilts towards augmented
sympathetic activity in prehypertensives. Moreover, the
contribution of altered vagal activity in the causation of
prehypertension and hypertension has not yet been fully
elucidated.
HRV has been used as a noninvasive tool to quantita-
tively estimate cardiac autonomic activity and it has
proved to be of prognostic significance in hypertension
[32-34]. HRV has been reported to be decreased in
hypertension and the magnitude of decrease in HRV
predicts the severity of hypertension [32]. HRV also has
emerged as a cardiovascular risk marker [30]. It has been
observed that among normotensive men, lower HRV has
a greater risk for developing hypertension, and auto-
nomic dysregulation has been documented in the early
stage of hypertension [33]. Thus, decreased HRV in pre-
hypertensives in the present study supports these earlier
reports and could also be used as a predictive tool for
the future development of hypertension in these sub-
jects. Moreover, it was reported earlier that changes in
cardiac autonomic function is associated with prevalent
hypertension and reduced vagal activity along with the
imbalance of sympathovagal function is associated with
the risk of developing hypertension [34]. Therefore, the
major findings of HRV analysis in the present study
depicting decreased HRV, increased sympathetic and
decreased parasympathetic drive indicate a similar pat-
tern of alteration in sympathovagal balance in prehyper-
tension as observed in hypertension earlier.
From the reports of the present study it appears that
decreased vagal tone plays a critical role in the shift of
this sympathovagal balance from the transition of
normotensive state to prehypertensive state, as evident
from decrease in TP and HFnu in prehypertensives
(Table 2). This is because the intensity of sympathovagal
imbalance (degree of increase in LF-HF ratio) was more
prominent in prehypertensive subjects with higher BMI
compared to prehypertensive subjects with normal BMI.
In prehypertensive subjects with higher BMI, though
there was increased sympathetic activity (increased
LFnu) and decreased parasympathetic activity (decreased
HFnu), the magnitude of change in vagal drive was more
than the change in sympathetic drive as there wassignificant difference in HFnu, but not LFnu between the
subjects of groups 2 and 3 (Table 2). Moreover, there
was significant decrease in the all time domain indices
(TDI) in group 3 subjects compared to that of both
group 1 and 2 subjects, but not in group 2 subjects com-
pared to the group 1 subjects. This indicates a profound
decrease in vagal tone in prehypertensive subjects with
higher BMI, as TDI in general reflect vagal modulation
of cardiac activities [24,30]. Also, the basal heart rate
was significantly more in prehypertensive subjects with
higher BMI (group 3) compared to both the normal
BMI subjects (groups 1 and 2), and there was no differ-
ence in BHR between normotensive subjects with nor-
mal BMI and prehypertensive subjects with normal BMI
(Table 1). This indicates a significantly lower vagal tone
in prehypertensive subjects with higher BMI as higher
basal heart rate is an index of poor vagal tone [36].
Thus, these findings suggest that vagal withdrawal plays
an important role in the alteration of sympathovagal bal-
ance with increase in BMI in prehypertensive subjects.
Reports of our recent studies indicate significant contri-
bution of vagal inhibition in the genesis of prehyperten-
sion in the young siblings of hypertensive parents
[18,19]. Hence, we assume that vagal withdrawal could
also be important in the causation of prehypertension in
adults.
From this study the exact cause of sympathovagal im-
balance in prehypertensive subjects can not be defini-
tively ascertained. Nevertheless, BMI could be a
potential factor for the causation of SVI as it was highly
correlated with LF-HF ratio in prehypertensive subjects
(Table 4). Moreover, BMI was strongly correlated with
all the cardiovascular parameters including SBP and
DBP in all prehypertensive subjects considered together
(Table 4). In addition, BMI emerged as an important
contributor to SVI in prehypertensives as it was found
to have independent correlation with LF-HF ratio
(Table 5) as determined by multiple regression analysis.
Increased adiposity could be a key determinant for the
development of prehypertension in susceptible indivi-
duals as obesity has been reported to be associated with
increased sympathetic and decreased parasympathetic
activity [37-40]. It was suggested that alteration in
plasma levels of leptin, neuropeptide-Y and α-MSH
(melanocyte-stimulating hormone) might be involved in
activation of sympathetic activity that leads to hyperten-
sion in obese patients [41]. Further, there are report on
cardiac dysfunctions associated with insulin resistance,
oxidative stress and inflammation that are dependent on
the quantity of fat mass in obese, but not in overweight
children [42]. Therefore, we assume that SVI caused by
increased adiposity is among the major predictors of in-
crease in blood pressure in prehypertensives. This was
further supported by the report of Schmid et al that
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in sympathetic tone and increased blood pressure in
young healthy overweight subjects [43]. Also, previous
studies have demonstrated that sympathetic activity nor-
malizes in overweight subjects following six-month cal-
orie restriction combined with exercise [44].
Though the exact mechanism of increased blood pres-
sure induced by sympathetic activation in obesity is not
known, it has been suggested that retrograde inflamma-
tion could be the pathophysiologic link as increased
sympathetic activity induces a proinflammatory state by
IL-6 production, which in turn results in an acute phase
response [45]. Also, increase in sympathetic activity has
been reported to elevate blood pressure by promoting
inflammation-mediated arterial rigidity in obesity [46].
As hyperinsulinemia is known to stimulate adrenergic
activity and hyperinsulinemia is observed in obesity, it
has been postulated that chronic hyperinsulinemia may
lead to enhanced sympathetic tone and cardiovascular
risk in obese patient [47]. Therefore, we propose to as-
sess the link of BMI with inflammatory markers and
hyperinsulinemia in the causation of SVI in prehyperten-
sives in our future studies.
RPP is an indirect measure of myocardial load and
oxygen consumption [29]. As degree of correlation of
LF-HF ratio and BMI with RPP was highly significant in
prehypertensives (Table 4), myocardial energy expend-
iture could be more in these subjects. Hence, the risk of
cardiovascular dysfunctions associated with prehyperten-
sion [9-11] may possibly be linked to the level of BMI
and RPP in these subjects.
Diastolic blood pressure (DBP) is the reflection of per-
ipheral vascular tone and resistance [48]. In the present
study, the degree of correlation of LF-HF ratio was max-
imum with DBP in groups 2 and 3 (Tables 3) and all the
prehypertensive subjects taken together (Table 4).
Hence, alteration in vascular tone could be directly
linked to the degree and nature of SVI and it appears
that BMI is an independent contributor to the genesis of
SVI in these subjects. Inspite of the limitations that we
have not performed direct assessment of sympathetic ac-
tivity, not measured cardiac functions and there is less
sample size of prehypertensive subjects having normal
BMI, the present study emphasizes the necessity to im-
prove vagal tone in individuals having blood pressure in
prehypertensive range so that the sympathovagal balance
is restored in these subjects and they do not progress
into the stage of clinical hypertension. As practice of
regular aerobic exercises such as morning walk, swim-
ming, cycling etc. and practice of yoga such as asanas,
meditation, pranayama etc. have been reported to de-
crease blood pressure, improve vagal tone and cardiac
health, and reduce body weight gain [44,47,49-51], pre-
hypertensive subjects should be encouraged to practicesuch program to prevent increase in their BMI and pro-
gression to hypertension.
Conclusion
In the present study, sympathovagal imbalance (SVI)
was observed in prehypertensive subjects, which was
mild in subjects with normal BMI and severe in subjects
with higher BMI. Vagal withdrawal was significantly
associated with sympathetic overactivity in prehyperten-
sive subjects. Magnitude of SVI (alteration in LF-HF
ratio) was correlated with BMI and diastolic blood pres-
sure. BMI had an independent contribution to change in
LH-HF ratio. It was concluded that BMI could be a
major predictor of SVI in prehypertensives. Hence, it
was advised that life style modifications should be
adopted by prehypertensives for achieving their effective
autonomic homeostasis.
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